FDA Action on Loperamide Misuse; Plus Phase 1 Trials for BAT2506 Biosimilar Begin
Trump Nominates MD Anderson Oncologist as U.S. FDA Commissioner
FDA Approves Ixekizumab for Treating Active Ankylosing Spondylitis
FDA Approves the Biosimilar Hadlima (Adalimumab-bwwd)
FDA Approves Upadacitinib for RA
FDA Approves AbbVie’s New Rheumatoid Arthritis Drug
FDA Approves Risankizumab, Adds Stronger Warning to Sleep Medications
Ixekizumab Promising for Non-Radiographic Axial SpA; Plus FDA Approves Belimumab for Pediatric Lupus
IV Meloxicam Stalls at FDA; Plus Health Canada Approves Risankizumab for Plaque Psoriasis
- 1
- 2
- 3
- …
- 7
- Next Page »